论文部分内容阅读
目的对老年糖尿病高血压合并高尿酸血症患者采用厄贝沙坦联合苯磺酸氨氯地平治疗的临床效果进行探讨分析。方法 87例糖尿病高血压合并高尿酸血症患者,随机将其分为观察组(45例)和对照组(42例),对照组患者仅应用厄贝沙坦治疗,观察组患者应用厄贝沙坦联合苯磺酸氨氯地平治疗。比较两组疗效。结果观察组治疗总有效率、血压等指标优于对照组(P<0.05);观察组血尿酸水平明显低于对照组(P<0.05)。结论对糖尿病高血压合并高尿酸血症患者采取厄贝沙坦联合苯磺酸氨氯地平治疗,能够有效降低患者的血压和血尿酸,可临床推广。
Objective To investigate the clinical effects of irbesartan combined with amlodipine besylate in senile patients with diabetes mellitus and hyperuricemia. Methods Eighty-seven patients with diabetes mellitus and hyperuricemia were randomly divided into observation group (n = 45) and control group (n = 42). Patients in the control group were treated with irbesartan only. Patients in the observation group were treated with irbesartan Tan combined with amlodipine besylate treatment. Compare the two groups curative effect. Results The total effective rate and blood pressure in the observation group were better than those in the control group (P <0.05). The serum uric acid level in the observation group was significantly lower than that in the control group (P <0.05). Conclusion The treatment of irbesartan combined with amlodipine besylate in patients with diabetes mellitus and hyperuricemia can effectively reduce the blood pressure and serum uric acid in patients with hypertension and can be clinically promoted.